Vaccine News and Research

RSS

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

HIV latent cells produce a possible cure investigation

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC) and their collaborators gave a presentation recently at AIDS 2022, the 24th International AIDS Conference in Montreal.

1 Aug 2022

Researchers analyze eight assemblers on viral sequencing data

On actual viral next-generation sequencing data, a recent study compares and evaluates eight de novo genome assembly software tools.

22 Jul 2022

Research highlights the impacts of biomolecules in plants over stress

Diphthamide is a biomolecule required for the correct synthesis of proteins in cells.

18 Jul 2022

Comparative mass spectrometry strategy determines the viral and cellular candidate proteins of poxvirus

Pox viruses get a head start on infecting a host by delivering a package of proteins that interferes directly with the innate immune system of the host.

15 Jul 2022

Researchers create antibodies against the SARS-CoV-2 from hen eggs

Scientists at the University of California, Davis, have created antibodies against the SARS-CoV-2 spike protein in hen eggs.

From The University of California, Davis 14 Jul 2022

Researchers work on DNA-delivered antibodies to stop COVID-19

A new COVID-19 antibody delivery approach has progressed to clinical trials, thanks to funding from the Defense Advanced Research Projects Agency (DARPA) and the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND).

11 Jul 2022

Challenges in Drug Discovery; Where are we now, and where are we going?

As part of our SLAS Europe 2022 coverage, we speak to Steve Rees, Vice-President of Discovery Biology at AstraZeneca, about the challenges currently faced by the drug discovery sector.

From Society for Laboratory Automation and Screening (SLAS) 8 Jul 2022

Researchers get funding to develop a vaccine against ALS disease

DZNE and Intravacc B.V., have received a grant from the European Union of € 2.5 million to further create a prototype ALS vaccine.

8 Jul 2022

COVID-19 vaccination stimulates antibodies aiming parts of virus spike protein among corona variants, researchers discover

Can the SARS-CoV-2 vaccine reactivate previously suppressed antibody responses and pave the way for a unified coronavirus vaccine?

8 Jul 2022

Scientists create new live-attenuated influenza vaccine technique over pathogens

The use of attenuated, live viruses as vaccines is a potential method to minimize the effects of viral infectious diseases, such as influenza.

8 Jul 2022

Study shows how drugs help to treat hepatitis A virus replication using an animal model

A virus must go through the viral replication cycle in order to propagate throughout the body and cause disease.

5 Jul 2022

Researchers capture a new high-resolution view of the rabies virus

Around 59,000 individuals are shockingly killed by the rabies virus each year, and several of them are children. Some victims, particularly children, discover they have been exposed after it is too late.

20 Jun 2022

New chemical-only process may represent an important breakthrough in creating customized mRNA vaccines

At the Nagoya University in Japan, scientists have come up with a new chemical-only process that might signify an essential discovery in making tailored mRNA vaccines for a range of diseases and enable the low-cost making of mRNA in large quantities.

9 Jun 2022

New supramolecular CRISPR–Cas9 carrier supports much effective genome editing

Clustered regularly interspaced short palindromic repeats (CRISPR) and their accompanying protein, CRISPR-associated protein 9 (Cas9), several years ago, made international news as a game-changing genome editing system.

18 May 2022

Scientists detect rare genetic signs of drug-resistant tuberculosis with the aim to stop disease progression

Many people believe tuberculosis (TB) is a disease of the past. Nonetheless, it claims over a million lives each year. Furthermore, the problem is escalating as Mycobacterium tuberculosis—the pathogen that causes tuberculosis develops resistance to the antibiotics used to treat the disease.

12 May 2022

Vaccine News and Research

Further Reading

HIV latent cells produce a possible cure investigation

Researchers analyze eight assemblers on viral sequencing data

Research highlights the impacts of biomolecules in plants over stress

Comparative mass spectrometry strategy determines the viral and cellular candidate proteins of poxvirus

Researchers create antibodies against the SARS-CoV-2 from hen eggs

Researchers work on DNA-delivered antibodies to stop COVID-19

Challenges in Drug Discovery; Where are we now, and where are we going?

Researchers get funding to develop a vaccine against ALS disease

COVID-19 vaccination stimulates antibodies aiming parts of virus spike protein among corona variants, researchers discover

Scientists create new live-attenuated influenza vaccine technique over pathogens

Study shows how drugs help to treat hepatitis A virus replication using an animal model

Researchers capture a new high-resolution view of the rabies virus

New chemical-only process may represent an important breakthrough in creating customized mRNA vaccines

New supramolecular CRISPR–Cas9 carrier supports much effective genome editing

Scientists detect rare genetic signs of drug-resistant tuberculosis with the aim to stop disease progression

RNA binding proteins in T cells help generate an effective immune response

Researchers analyze the potential role of mRNA in drug development and novel therapies

Sartorius Launches the Octet® SF3 SPR System, Strengthening its Leadership in Advanced Label-Free Bioanalytics

CD8 + Tscm may has protective immunity to hepatitis C virus infection

SARS-CoV-2 can directly infect a specialized type of kidney cell

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics